Glaucocalyxin A

CAS No. 79498-31-0

Glaucocalyxin A ( —— )

Catalog No. M19111 CAS No. 79498-31-0

Glaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 90 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Glaucocalyxin A
  • Note
    Research use only, not for human use.
  • Brief Description
    Glaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery.
  • Description
    Glaucocalyxin A-SBE-β-CD could be useful with a better solubility and sustained function in drug delivery. Glaucocalyxin A activates caspase-3, decreases BAD phosphorylation, and reduces the expression of X-linked inhibitor of apoptosis protein. Glaucocalyxin A inhibits Akt phosphorylation, suppresses proliferation, and promotes apoptosis in a dose-dependent manner, but not in normal glial cells. Glaucocalyxin A inhibits collagen-stimulated tyrosine phosphorylation of Syk, LAT, and phospholipase Cγ2, the signaling events in collagen receptor GPⅥ pathway. Glaucocalyxin A could potentially be developed as an antiplatelet and antithrombotic agent, can inhibit platelet p-selectin secretion and integrin activation by convulxin, is a GPVI selective ligand.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    Caspase-3;Akt
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    79498-31-0
  • Formula Weight
    332.44
  • Molecular Formula
    C20H28O4
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CC1(C2CC(C34C(C2(CCC1=O)C)CCC(C3O)C(=C)C4=O)O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Nimotuzumab

    Nimotuzumab is a humanized therapeutic monoclonal antibody against epidermal growth factor receptor EGFR).

  • Icotinib

    Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM.

  • FRAX1036

    FRAX-1036 is a effective and selective PAK1 inhibitor.